Publications

5674 Results

Effect of finasteride on urinary outcomes after benign prostatic hyperplasia surgery: secondary analysis of the Prostate Cancer Prevention Trial

Authors
C Chestnut;C Yang;J Gore;J Schenk
Journal / Conference
American Urological Association Annual Meeting (April 26-29 (Saturday-Tuesday, Las Vegas NV)
Year
2025
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Efficacy and Safety of Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors After Progression on Prior Therapy: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)

Authors
J Strosberg;T Zemla;S Geyer;S Pulsipher;S Behr;N Raj;N Vijayvergia;NA Dasari;J Meyerhardt;E Wolin;T Halfdanarson;J Chan
Journal / Conference
ENETS (European Neuroendocrine Tumor Society) meeting (Mar 5-7, 2025, Krakow, Poland)
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021602

Prognostic and predictive role of T cell infiltration in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702

Authors
Y Takashima;C Ma;Q Shi;A Dias Costa;T Twombly;J Vayrynen;M Zhao;A Shergill;P Kumar;F Couture;P Kuebler;S Krishnamurthi;B Tan;E O'Reilly;A Shields;S Ogino;C Fuchs;J Meyerhardt;J Nowak
Journal / Conference
AACR Annual Meeting (April 25-30, 2025, Chicago, IL)
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Harnessing Artificial intelligence in Data Management

Authors
C Cook;A Hoering;M LeBlanc
Journal / Conference
Society for Clinical Trials (May 18-21, 2025, Vancouver, CAN)
Year
2025
Research Committee(s)
Multiple sites

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Vaginal Cancers

Authors
Y Chae;J Czeskleba;S Patel;A Menter;W Robinson;N Jones;M Rampurwala;A Naing;J Beck;C Moloney;L Chung;C McLeod;H Chen;E Sharon;S Threlkel;M Othus;C Ryan;C Blanke;R Kurzrock
Journal / Conference
AACR 2025 Meeting, poster; Cancer Res 2025;85(8_Suppl_2):Abstract nr CT092
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

Authors
K Kendra;S Bellasea;Z Eroglu;S Hu-Lieskovan;K Campbell;W Carson;D Wada;J Plaza;J Sosman;G In;A Ikeguchi;J Hyngstrom;A Brohl;N Khushalani;J Markowitz;G Negrea;S Kasbari;G Doolittle;U Swami;T Roberts;E Medina;I Baselga Carretero;C Gonzalez;I Perez Garcilazo;A Vega-Crespo;J Ming Chen;N Naser Al Deen;S Patel;E Sharon;J Moon;M Wu;A Ribas
Journal / Conference
Nature Medicine
Year
2025
Research Committee(s)
Melanoma
PMID
PMID40813711
Study Number(s)
S1512

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000 (NCT# 04511013)

Authors
Z Eroglu;J Moon;Y Najjar;R Kotecha;M Wu;V Spektor;N Khushalani;L Korde;E Sharon;K Grossmann;J Kirkwood;J Wolchok;S Patel;H Tawbi
Journal / Conference
ASCO Annual Meeting (May 30-June 3, 2025, Chicago, IL), oral, Abstract # LBA9507
Year
2025
Research Committee(s)
Melanoma
Study Number(s)
S2000

(S1900E: A Phase II Study of AMG 510 in Patients With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN Lung-Map Sub-Study))

Authors
S Padda;M Redman;D Gerber;K Minichiello;D Mehta;S Mashru;H Hakim;J Brahmer;J Bradley;T Stinchcombe;J Gray;K Kelly;D Kozono;M Edelman;K Reckamp;H Borghaei;R Herbst;S Ramalingam;J Neal
Journal / Conference
ASCO Annual Meeitng (May 30-June 3, 2025, Chicago), rapid oral, Abstract # 8518
Year
2025
Research Committee(s)
Lung
Study Number(s)
S1900E

Androgen pathway gene expression and response to hormonal therapy in prostate cancer (SWOG S1216)

Authors
J Pinski;S Ingles;Z Minojlovic;S Xiong;D Weisenberger;A Goldkorn;C Tangen;D McConkey;P Lara;M Hussain;D Quinn;I Thompson;S Lerner;T Dorff;N Agarwal
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), publication only, Abstract # e17109
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
S1216

Prognostic Value of Circulating Tumor DNA in Advanced Stage Classic Hodgkin Lymphoma Patients Treated on SWOG S1826

Authors
J Paczkowska;M Kaczkowiak;M LeBlanc;C Stewart;A Herrera;J Fernando del Castillo;S Castellino;S Rutherford;A Evens;K Davison;H Li;D Neuberg;M Murakami;J Makker;B Kahl;J Leonard;N Bartlett;S Smith;J Song;K Kelly;G Getz;JW Friedberg;M Shipp
Journal / Conference
ICML 2025 Meeting (Lugano, Switzerland, from 17 to 21 June 2025)
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826